Envestnet Portfolio Solutions, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1998033 BERWYN, PA

Position in VRTX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$4,005,630

+$122,072 QoQ

Shares Held

8,064

-7.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#522

of 1,735 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Envestnet Portfolio Solutions, Inc. holds $15,944,229 across 18 Biotechnology names. VRTX ranks #1 (25.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	8,064	$4,005,630
2	JAZZ	Jazz Pharmaceuticals plc	8,030	$1,934,989
3	ALNY	Alnylam Pharmaceuticals, Inc.	4,635	$1,395,274
4	TGTX	Tg Therapeutics, Inc.	21,192	$1,164,288
5	PTCT	Ptc Therapeutics, Inc.	13,730	$1,119,956
6	CORT	Corcept Therapeutics Inc	10,617	$923,148
7	HALO	Halozyme Therapeutics, Inc.	11,409	$892,982
8	CPRX	Catalyst Pharmaceuticals, Inc.	21,996	$691,334

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,005,630	8,064	-7.3%	Shares	Sole	2026-07-20
2026-03-31	$3,883,558	8,697	-47.2%	Shares	Sole	2026-04-29
2025-12-31	$7,466,385	16,469	-9.6%	Shares	Sole	2026-02-06
2025-09-30	$7,136,072	18,221	+5.4%	Shares	Sole	2025-10-30
2025-06-30	$7,699,288	17,294	+1.6%	Shares	Sole	2025-07-25
2025-03-31	$8,252,606	17,022	-11.6%	Shares	Sole	2025-04-21
2024-12-31	$7,751,572	19,249	-48.0%	Shares	Sole	2025-02-10
2024-09-30	$17,220,052	37,026	-1.7%	Shares	Sole	2024-10-31
2024-06-30	$17,659,963	37,677	+3.4%	Shares	Sole	2024-07-16
2024-03-31	$15,227,268	36,428	+14.1%	Shares	Sole	2024-05-06
2023-12-31	$12,986,708	31,917	+2.0%	Shares	Sole	2024-02-07
2023-09-30	$10,885,652	31,304	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.